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Abstract The human artificial chromosome (HAC) vector is
a promising tool to improve the problematic suppression and
position effects of transgene expression frequently seen in
transgenic cells and animals produced by conventional plas-
mid or viral vectors. We generated transgenic mice maintain-
ing a single HAC vector carrying two genomic bacterial
artificial chromosomes (BACs) from human HLA-DR loci
(DRA and DRB1). Both transgenes on the HAC in transgenic
mice exhibited tissue-specific expression in kidney, liver,
lung, spleen, lymph node, bone marrow, and thymus cells in
RT-PCR analysis. Stable functional expression of a cell sur-
face HLA-DR marker from both transgenes, DRA and DRB1
on the HAC, was detected by flow cytometric analysis of
splenocytes and maintained through at least eight filial gener-
ations. These results indicate that the de novo HAC system
can allow us to manipulate multiple BAC transgenes with
coordinated expression as a surface antigen through the
generation of transgenic animals.
Introduction
Transgenic animals have provided tools for investigating
many biological problems. Genomic fragments cloned by
bacterial artificial chromosomes (BACs) have been utilized
to generate transgenic animals when tissue-specific or tempo-
rally controlled expression of transgenes is desired. Due to the
large insert capacity (∼350 kb) of a BAC vector, the genomic
fragments can often possess the complete promoters and
control elements of the gene of interest (Asami et al. 2011).
In addition, BAC transgenes seem to be more resistant to
position effects than smaller transgenes, such as artificial
expression cassettes with complementary DNA (cDNA)
(Gong et al. 2003). Typically, BAC transgenic mice are gen-
erated bymicroinjection of the BACDNA into the pronucleus
of fertilized mouse eggs (Vintersten et al. 2008). However, in
principle, this method causes random integration (non-
specific insertion) of BAC DNAs into the mouse genome,
and the number of insertion copies is variable. Increased copy
number of a BAC transgene correlates with increased expres-
sion of the BAC transgene (Chandler et al. 2007). When
investigating the cooperation of two transgenes in a transgenic
mouse, generally two characterized transgenic mouse lines are
crossed, but this is a time-consuming method and maintaining
an appropriate level of gene expression is difficult.
A de novo human artificial chromosome (HAC) was con-
structed with naked human centromeric repetitive DNA
(Harrington et al. 1997; Ikeno et al. 1998) and a HAC vector
system developed in which one copy of a DNA fragment can
be handled by Cre/lox insertion and transferred into a variety
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of vertebrate cell lines (Ikeno et al. 2009; Iida et al. 2010). A
HAC is an episomal vector that can harbor a large DNA and is
exploitable for generating transgenic animals using embryonic
stem (ES) cell technology (Kazuki and Oshimura 2011; Ikeno
et al. 2012). Thus, the HAC system can avoid the copy
number problem and/or position effects caused by non-
specific insertion of the BAC transgene. The HAC vector is
expected to be available for the production of transgenic mice
carrying two or more single-copy genes with a large control
region over tens of kilobases. Recently, a transgenic mouse
harboring a single copy of a HAC, termed a trans-mini-
chromosomal (TMC) mouse, carrying three continuous non-
correlated genes from the human genome was generated by
inserting a single BAC DNA from chromosome 21
(Miyamoto et al. 2014). However, whether two or multiple
independent BAC transgenes can be gathered onto a single
HAC and cooperatively function in a transgenic mouse has
not been investigated.
Here, we describe a transgenic mouse using a HAC vector
carrying two single-copy human HLA-DR genomic genes.
HLA-DR is a major histocompatibility complex (MHC) class
II cell surface receptor consisting of an αβ heterodimer. We
introduced a DR α-chain (HLA-DRA locus) and DR β-chain
(HLA-DRB1*0405 locus) into a single HAC vector (HLA-
HAC). In transgenic mice harboring HLA-HAC (carrying
HLA-DRA and DRB1 genes), tissue-specific expression of
human MHC class II cell surface receptor in spleen cells was




Chinese hamster ovary (CHO) cells were cultured in Ham’s F-
12 nutrient mixture (Wako) supplemented with 10 % fetal
bovine serum (FBS) at 37 °C and 5 % CO2. The mouse ES
cells were maintained on feeder cells in an ES cell medium
consisting of Dulbeccos’ modified Eagle’s medium (DMEM)
(Kohjin Bio) supplemented with 20 % FBS, 0.1 mM non-
essential amino acids (Gibco), 2 mM glutamine (Gibco),
1000 U/ml ESGRO (Chemicon), and 0.1 mM β-
mercaptoethanol (Sigma).
Microcell-mediated chromosome transfer
Microcell-mediated chromosome transfer (MMCT) from
CHO cells to mouse ES cells was carried out as described
previously (Suzuki et al. 2006). Briefly, twenty 10-cm dishes
of CHO cells were grown to 70 % confluency and Colcemid
(Wako) added to 0.05 μg/ml. The cells cultured for 72 h were
harvested by trypsinization and resuspended in pre-warmed
serum-free DMEM (Wako) containing Cytochalasin B
(Calbiochem) at a final concentration of 20 μg/ml. The sus-
pension was incubated, and then an equal volume of Percoll
(Amersham Biosciences) was added. The suspension was
centrifuged in a Hitachi R20A2 rotor at 15,000 rpm for
90 min at 37 °C. The microcell fraction containing the
HLA-HAC was mixed with ES cells. After centrifugation at
2000 rpm for 5 min, the pellet was suspended in 1 ml 50 %
PEG1500 (Roche). The fusion product was washed and plated
onto three 10-cm dishes layered with feeder cells. ES cells
containing the HLA-HAC were selected with 150 μg/ml
G418 (Sigma).
Generation of chimeric mice
Chimeric mice were produced from mouse ES cell lines. The
ES cells were aggregated with eight-cell embryos derived
from BDF2 mice and then transferred into pseudopregnant
ICR females. Almost 100 % coat color chimeric mice were
mated with C57BL/6 (B6) mice (Jackson Laboratory) to ob-
tain transgenic mice. All animal experiments were approved
by the Institutional Animal Care and Use Committee of
RIKEN RCAI and Kazusa DNA Research Institute.
HLA-DR gene constructs
We used a whole CTD-2052L14 BAC clone (100 kb) as the
HLA-DRA gene because this BAC contains only the HLA-
DRA gene (referenced on NCBI CloneDB browser; http://
www.ncbi.nlm.nih.gov/clone/79827/). The DRA-BAC used
in this study contains an upstream 22-kb region and the
HLA-DRA gene (Fig. 1a). Only a 268-base pair region of
the 5′-flanking region of the HLA-DRA gene has been report-
ed to be sufficient for the cell type-specific expression on the
transgenic mouse as a multi-copy in this case (Fukui et al.
1993). So, we included the longer upstream region. On the
other hand, for the cis-elements of the DRB1 gene, consensus
has not yet been reached; therefore, we used the maximum
length of the upstream region, close to the border of the next
pseudo gene. A HLA-DRB1*0405 BAC was constructed
from a 28.5-kb upstream region of the HLA-DRB1*0103
gene in a RP11-379F19 BAC clone (referenced on NCBI
CloneDB browser; http://www.ncbi.nlm.nih.gov/clone/
312446/) and genomic DNA (IHW09415) containing all
exons of HLA-DRB1*0405 by using a Red recombination
with pBADTcTypeG plasmids whose mutant Redα and mu-
tant Redβ proteins increase the recombination efficiency
(Nakayama and Ohara 2005). Consequently, the 50-kb BAC
had 28.5 kb upstream of the translational start site and all
exons and introns of the HLA-DRB1*0405 gene (Fig. 1a).
The HLA-DRA and DRB1 BACs were modified by addition
of the lox66/puromycin resistance cassette or lox66/
blasticidin S resistance cassette, respectively (Fig. 1), in place
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of loxP by the Red recombination in Escherichia coli accord-
ing to a previously described method (Ikeno et al. 2009).
DNA transfection
For the insertion of the HLA-DR BACs into the HAC vector,
1 μg of the HLA-DR BAC DNA was co-transfected with
0.5 μg of CAGGS-Cre into CHO cells (5×105) retaining the
HAC vector (Ikeno et al. 2009) with FuGENE HD (Promega)
according to the manufacturer’s instructions. DRA cell lines
were selected with 6 μg/ml puromycin (Sigma) and DRB1
cell lines with 3 μg/ml blasticidin S (Wako).
Real-time quantitative PCR analysis
Total RNAwas isolated using the RNeasyMicro Kit (Qiagen).
cDNAwas synthesized using the Verso cDNA Synthesis Kit
(Thermo Scientific), and 25-ng aliquots were used for PCR.
Real-time PCRwas carried out using the ABI 7500 Real-Time
PCR System (Applied Biosystems). PCR reactions were car-
ried out using the Luminaris Probe Low ROX qPCR Master
Mix (Thermo Sc ien t i f i c ) and each assay mix :
Hs00219578_m1 (HLA-DRA), Hs00830030_sH (HLA-
DRB1), or Mm99999915_g1 (mouse GAPDH). The PCR
protocol was 95 °C for 10 min and 40 cycles of 95 °C for
15 s and 60 °C for 60 s.
Genomic PCR analysis
Genomic DNAwas extracted frommouse tails using aWizard
Genomic DNA Purification Kit (Promega) and PCR per-
formed as follows. The amplification conditions were 98 °C
for 1 min, followed by 35 cycles of 98 °C for 10 s, 60 °C for







TGG-3′ and 5′-TCCACTGTGAGAGGGCTCATC-3′; HLA-
DRB1-3, 5′-GTGGGAGATGCAGACTTGTGG-3′ and 5′-
Fig. 1 Generation of mice with HACs containing human genes. a
Introduction of the lox66 site into the HLA-BAC by Red recombination
in E. coli. b Schematic representation of two consecutive introductions of
HLA-BACs into a HAC vector using Cre/lox recombination. The gene in
the entry vector was inserted into a HAC vector in CHO cells by Cre/lox
recombination. Successful recombinants were selected by puromycin
(puro) or blasticidin (bsd) resistance. c HLA-HAC transfer from CHO
cells to mouse ES cells was achieved by MMCT. d Chimeric mice with
HLA-HAC were created by aggregation of the ES cells with BDF2 eight-
cell embryos




Fluorescent in situ hybridization
Fluorescent in situ hybridization (FISH) analysis was carried
out according to conventional procedures. To detect HACs,
biotin-labeled α21-I alphoid DNA (11-4) (Ikeno et al. 1994)
and digoxigenin-labeled pBelo-BACwere used as probes. For
dual FISH, biotin-labeled DNA was visualized with FITC-
conjugated avidin (Vector) and digoxigenin-labeled DNA
with TRITC-conjugated antidigoxigenin antibody (Roche).
Preparation of spleen cells
Splenocytes were smashed with two slide glasses, filtered
through a 70-μm cell strainer, and washed with Roswell
Park Memorial Institute (RPMI) medium (Wako). The super-
natant was removed and the red blood cells were destroyed
with Red Blood Cell Lysing Buffer Hybri-Max (Sigma). Cells
were washed with RPMI medium containing 10 % FBS and
then resuspended in the same medium.
Flow cytometry
Cells were stained with the antibody against HLA-DR conju-
gated with Alexa Fluor 488 (50 μg/ml, L243, BioLegend) for
30 min on ice. Flow cytometric analysis was performed using
a FACS Calibur instrument (BD Biosciences) and the results
analyzed using the FlowJo software program (Tree Star).
Results
Introduction of HLA-BACs into a HAC vector in CHO cells
The HLA-BACs with lox66/puromycin or blasticidin S resis-
tance cassette were inserted into a HAC vector in CHO cells
by Cre/lox recombination. Successful Cre-lox recombination
between the lox66 site at the promoterless cassette (puro or
bsd) on the BAC and the lox71 site of the gene expression
cassette on the 25-4 HAC vector produced drug-resistant cell
lines (puro or bsd; Fig. 1). PCR analysis of drug-resistant cells
after the first insertion of the HLA-DRA BAC into the 25-4
HAC showed that 22 of 31 cell lines had successful insertion.
The second insertion of the HLA-DRB1*0405 BAC was
performed using the first insertion-positive cell line (No. 11;
Fig. 2a). The 25-4 HAC vector carrying HLA-DRA BAC
(DRA-HAC) and carrying both HLA-DRA BAC and HLA-
DRB1*0405 BAC (HLA-HAC) was stably maintained as an
extra chromosome through Cre-lox reactions in CHO cells
(Fig. 2b).
Transfer of the HACs into mouse ES cells by MMCT
We used mouse ES cells (1×107 cells) and microcells pre-
pared from CHO cells (1×107 cells) containing DRA-HAC or
HLA-HAC for the MMCT (Doherty and Fisher 2003,
Fig. 1c). We obtained over 70 mouse ES cell colonies
screened by G418 resistance and analyzed 10 colonies by
FISH. The majority of each ES cell lines carried a single copy
of the HACwith no integration signal of the HACDNA in the
mouse chromosomes (Fig. 3a, b). Karyotype analysis showed
that the number of cells with a normal mouse karyotype
(retaining 40 mouse chromosomes) varied between 30 and
100 % among ES cell lines (Fig. 3b). We used cell line No. 9
because 10 of 10 analyzed cells showed normal karyotypes
and contained a single HLA-HAC for chimeric mouse
production.
Chimeric mice carrying the HACs
Chimeric mice carrying the DRA-HAC or HLA-HAC were
created by aggregation of the ES cells with BDF2 eight-cell
embryos. Three male mice with a high degree of chimerism
(almost 100 % in coat color, Fig. 3c) were investigated for
germ line transmission of the HLA-HAC. After crossing the
chimeric male mice with five female B6 mice, 6-week-old F1
offspring (39 F1 mice) were analyzed by PCR using HAC-
specific primers; 35.3–58.3 % of these F1 offspring were
positive for the HAC signals (Table 1). Thus, HLA-HACs
were transmitted through the germ line of all of the chimeric
mice we examined, and a total of 46.2% of F1 offspring (18 of
39) possessed the HLA-HAC (maximum expected value was
50 %). On the other hand, three chimeric male mice harboring
the DRA-HAC were crossed with six female B6 mice; 47.1–
53.3 % of these F1 offspring were positive for the HAC
signals (Table 1). A total of 49.1 % of F1 offspring (26 of
53) possessed the DRA-HAC. Because the ES cell line used in
this experiment was selected carefully by karyotype analysis
and HAC retention rate, we effectively obtained chimeric
mice with chimeric rates and HAC transmission rates that
were high enough.
Mitotic stability of the HACs in mouse somatic tissues
To investigate the mitotic stability of HACs in the somatic
tissues of mice, the retention of HLA-HAC in cells from the
bone marrow, brain, heart, kidney, liver, spleen, and tail of
7 months old F1micewas analyzed by FISH. As expected, the
HLA-HACs were retained in all of these tissues (Fig. 4a, b).
The retention rate in the brain, heart, kidney, liver, and tail at
7 months (highest individual (male) 90.0–96.7 %, lowest
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individual (female) 56.7–73.3 %) was similar to that of tail
cells from a 6-week-old mouse (highest individual 96.7 %,
lowest individual 60.0 %; Table 2). In contrast, the HAC
retention rate of the bone marrow and spleen was lower than
that of the other tissues (highest individual 73.3 and 76.7 %,
lowest individual 43.3 and 40.0 %, respectively). The HAC
Fig. 2 HLA-BAC introduction
into a HAC vector in CHO cells. a
PCR analysis of two consecutive
introductions of HLA-BACs into
a HAC vector using site-specific
recombination. The first and sec-
ond introductions of BAC were
confirmed by PCR with the CAG
promoter and puro sequences (22
positive in 31 analyzed) and the
CAG promoter and bsd sequences
(19 positive in 20 analyzed), re-
spectively. b FISH analysis of the
HLA-HAC (arrowhead) in CHO
cells. This HAC carried a single
copy of HLA-DRA BAC and a
single copy of HLA-DRB1 BAC,
confirmed by a further insertion
of a DNA fragment to the re-
maining cassettes on the HAC
and PCR analysis (data not
shown). The red signal shows
BAC DNA, the green signal
shows alphoid DNA and the
white signal shows DNA coun-
terstained with DAPI
Chromosoma (2015) 124:107–118 111
retention rates in the tissues varied among F1 mice, but they
were represented in tail cells.
Retention and transmission of the HACs through mouse
generations
To investigate the retention and transmission rates of HACs in
the TMC mouse and the stability of the large insert genes on
the HAC through mouse generations, F1 mice were
backcrossed with B6 mice for seven more generations for a
total of eight backcrosses. “The HAC transmission” of all
pups was examined by PCR analysis of genomic DNA ex-
tracted from the 3-mm tail of each mouse with HAC-specific
primers. “The retention rate of the HAC” in tail cells from the
PCR positive mouse was examined by FISH analysis. (The
PCR band-negative mice did not show any HAC FISH sig-
nal.) In F1 mice, the retention rates of HLA-HAC and DRA-
HAC were similar on average but variable in individual mice
(average 82.6 and 86.2 %, respectively; Tables 2 and 3). The
retention rate of HLA-HAC in tail cells through mouse gen-
erations was 70–80 %, whereas the retention rate of DRA-
HAC was around 90 % (Fig. 5a). Unexpectedly, a significant
difference was observed in the transmission rate between the
two types of HACs through mouse generations. The transmis-
sion rate of DRA-HAC was very close to the maximum
expected value of 50 % (average 45.9 %, 61/133 mice)
through eight generations, but the transmission rate of
HLA-HAC varied in lower ranges (average 23.5 %, 38/
162 mice, Fig. 5b). Clearly, the additional insertion of the
DRB1 BAC into another gene expression cassette site on
the HLA-HAC caused some instability in the HAC
through the mouse generations. However, all HACs were
detected as extra-chromosomal signals independently from
endogenous mouse chromosomes, though we observed
Fig. 3 Generation of TMC mice.
a FISH analysis of the HLA-HAC
in mouse ES cells. The mouse ES
cell lines carrying HLA-HAC
(arrowhead) were established by
MMCT. The red signal shows
BAC DNA, the green signal
shows alphoid DNA and the
white signal shows DNA coun-
terstained with DAPI. b Karyo-
type analysis of mouse ES cells
harboring HLA-HAC. An
asterisk (*) indicates the clone
used for generation of the TMC
mouse. c Chimeric mouse from
mouse ES/HLA-HAC. The coat
color of the mouse ES cell is
agouti. This mouse is almost
100 % ES cell-derived








HLA-HAC male No. 1 12 7 58.3
HLA-HAC male No. 2 10 5 50.0
HLA-HAC male No. 3 17 6 35.3
HLA-HAC male total 39 18 46.2
DRA-HAC male No. 4 15 8 53.3
DRA-HAC male No. 5 17 8 47.1
DRA-HAC male No. 6 21 10 47.6
DRA-HAC male total 53 26 49.1
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over 6000 cell samples in the FISH analyses. We also
confirmed by genomic PCR that the structures of the HLA
genes on the HACs were stably maintained through HAC
transfer into the mouse and eight consecutive mouse gen-
erations (Supplemental Fig. S1).
Functional expression of HLA-DR genes from the HLA-HAC
The expression of HLA-DRA and HLA-DRB1 as cell surface
antigens was evaluated by flow cytometry using splenocytes
from chimeric mice and anti-HLA-DR antibody. The cell
surface signals were detected specifically from the chimeric
mouse carrying the HLA-HAC (13.5 % of cell population,
Fig. 6a). Because the antibody binds a conformational epitope
on HLA-DRα that depends on the correct folding of the αβ
heterodimer (Moro et al. 2005), the result clearly indicates that
the HLA-DRA and HLA-DRB1*0405 genes from the HLA-
HAC were expressed and folded as a αβ heterodimer on the
cell surface of splenocytes in the chimeric mouse. Functional
expression was also observed in the eighth-generation TMC
mice (18.9 % of cell population, Fig. 6b), indicating that such
functional expression of the human genes on the HAC was
maintained through mouse generations. It was reported that
only about a half population (51.6 %) of splenocytes was
expressing endogenous class II MHC on their cell surface by
flow cytometric analysis in B6 wild-type mice (Jux et al.
2013). According to this data, an expected population of the
splenocytes expressing the HLA from the HAC in the chime-
ric mouse is estimated to be approximately 20–37 % (40–
73% splenocytes retain the HLA-HAC; Fig. 4a) and that in F8
mouse is approximately 22–30% (44–60% splenocytes retain
the HLA-HAC estimating from the 74 % HAC retention rate
in the tail cells; Fig. 5a). The actual measurements of the cell
surface signals by flow cytometry using splenocytes are
13.5 % in the chimeric mouse and 18.9 % in the F8 mouse.
These values, more than a half or very close to the expected
values estimated from mouse endogenous class II MHC ex-
pression, are significant enough for considering transgenic
human class II MHC genes on the HAC vector in mice
through generations.
Fig. 4 Characteristics of
transgenic mice harboring HLA-
HAC. a HLA-HAC retention rate
in the bone marrow, brain, heart,
kidney, liver, spleen, and tail of a
7-month-old F1 mouse. The per-
centage of HAC-retaining cells
was calculated from 60 cells. b
Metaphase chromosomes from
the spleen and interphase nuclei
from the heart of a 7-month-old
F1 mouse (the highest HAC re-
tention male in Table 2) were an-
alyzed by probing for alphoid and
BAC DNA in FISH
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Tissue-specific expression of HLA-DR genes from the HAC
in mice
The expression of MHC class II molecules is basically con-
fined to immunocompetent cells, such as B cells, macro-
phages, dendritic cells, and thymic epithelial cells. To deter-
mine whether the HLA-DR genes on the HACwere expressed
in a tissue-specific manner in eighth-generation TMC mice,
total cellular RNA was extracted from various tissues and
examined by real-time quantitative PCR analysis. The results
show that the expression pattern was similar between the two
individuals (Fig. 7 and Supplemental Fig. S2). The expression
levels of the HLA-DRA and HLA-DRB1 genes were high in
the lung, spleen, lymph node, and thymus, but they were
extremely low in the liver, kidney, and bone marrow. These
results indicate that the natural patterns of tissue-specific
expression of the human HLA-DRA and HLA-DRB1*0405
genes were almost mimicked on the HAC through the mouse
generations. On the other hand, the expression pattern of these
two genes on the HAC in CHO and ES cells was stochastic
(Supplemental Fig. S3). The No. 9 ES cell line used for
chimeric mouse production showed little, if any, HLA-DRA
and HLA-DRB1*0405 expression. Thus, human HLA-DR
genes including regulatory elements and promoters used in
this study acquired precise expression epigenetically in spe-
cific cell types through the mouse developmental process.
Discussion
We generated transgenic mice using a HAC carrying two
single-copy HLA-DR genes. For the past 20 years, many
HLA-DR transgenic mice, including those with an immuno-
deficient NOG background, have allowed the analysis of
HLA-restricted responses with variable success (Fukui et al.
1993; Suzuki et al. 2012). This study is the first report of
transgenic mice carrying two single-copy human genes com-
posed of human regulatory elements and exon-intron struc-
tures. Both the HLA-DRA and HLA-DRB1 genes on the
HAC were expressed in a tissue-specific manner and exhibit-
ed functional expression as a cell surface receptor in the TMC
mouse. The tissue-specific expression pattern of HLA-DR in
Table 2 HAC retention rate in the tail cells of 6 weeks old F1 HLA-HAC
mice
HAC retention rate (%) Sex of offspring Parental origin
60.0 ♀b No. 2♂
66.7 ♂ No. 1♂
66.7 ♀ No. 2♂
73.3 ♂ No. 3♂
76.7 ♀ No. 3♂
76.7 ♂ No. 1♂
80.0 ♂a No. 2♂
83.3 ♂ No. 3♂
86.7 ♀ No. 3♂
86.7 ♀ No. 3♂
86.7 ♂ No. 3♂
86.7 ♂ No. 1♂
90.0 ♀ No. 1♂
90.0 ♀ No. 2♂
90.0 ♂ No. 2♂
93.3 ♀ No. 1♂
96.7 ♂b No. 1♂
96.7 ♂ No. 1♂
Average 82.6
a The first mouse used for HAC transmission through eight generations
bMice used for analyzing the HAC retention rate in the bone marrow,
brain, heart, kidney, liver, spleen, and tail of 7-month-old F1 mice (see
also Fig. 4a, b)
Table 3 HAC retention rate in tail cells from 6-week-old F1 DRA-HAC
mice
HAC retention rate (%) Sex of offspring Parental origin
63.3 ♂ No. 4♂
66.7 ♂ No. 6♂
76.7 ♀ No. 4♂
80.0 ♀ No. 5♂
80.0 ♀ No. 6♂
83.3 ♀ No. 4♂
83.3 ♂ No. 4♂
83.3 ♂ No. 5♂
83.3 ♀ No. 6♂
83.3 ♂ No. 6♂
86.7 ♂ No. 4♂
86.7 ♂ No. 5♂
90.0 ♀ No. 4♂
90.0 ♀ No. 5♂
90.0 ♀ No. 5♂
90.0 ♂ No. 5♂
90.0 ♂ No. 5♂
90.0 ♀ No. 6♂
90.0 ♀ No. 6♂
90.0 ♂ No. 6♂
93.3 ♀ No. 4♂
93.3 ♂ No. 4♂
93.3 ♀ No. 6♂
93.3 ♀ No. 6♂
93.3 ♂a No. 6♂
96.7 ♂ No. 5♂
Average 86.2
a The first mouse used for HAC transmission through eight generations
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the TMC mouse was similar to that of endogenous class II
MHC genes in mice. The mRNA expression level of the class
II MHC in mice was high in the spleen and thymus, but it was
barely detectable in the liver, kidney, and bone marrow
(Pinkert et al. 1985). A previous report of a mouse carrying
12 copies of 24 kb of the HLA-DRA gene showed that the
transgene was overexpressed in some tissues and moderately
in other tissues (Altmann et al. 1993). In another transgenic
mouse, a 6-kb HLA-DRA gene fragment was integrated into
the X chromosome and subjected to random inactivation
(Fukui et al. 1993). Based on these observations, our present
analysis indicates that the features of HAC, an episomal vector
with a large DNA capacity and a controllable gene number,
were exploited effectively for the production of HLA-DR
transgenic mice. Furthermore, HLA-HACs were transmitted
through at least eight generations, and HLA-DR genes on the
HAC maintained functional expression during that time. We
also confirmed that two human genes that were reorganized on
the HAC were cooperatively expressed in immunocompetent
cells in mice. Taking account of these results, although we
checked only small fragments of the genes on the HAC
by PCR (Supplemental Fig. S1), it is conceivable that at
least no major rearrangement influencing the functional
expression was observed on the HACs through eight
mouse generations.
There are over 40 haplotypes of HLA-DRB, but only one
functional type of HLA-DRA in the Japanese population. We
have already generated a DRA-HAC mouse that harbors a
HAC vector carrying only an HLA-DRA locus. Recently, the
novel transgenic technique pronuclear injection-based
targeted transgenesis (PITT) was reported (Ohtsuka et al.
2010; Ohtsuka et al. 2012). The PITT technique enables
targeted integration of a single-copy transgene into a
predetermined locus by Cre-loxP-mediated recombination
and guarantees a stable and reproducible transgene expres-
sion. A combination of the DRA-HAC mouse and such a
technique will allow the generation of more HLA-DR
haplotypes.
Fig. 5 The retention and transmission rates of HAC. a The retention rate
of HAC in tail cells was determined by FISH analysis using alphoid and
BACDNAprobes. The percentage of HAC-retaining cells was calculated
from 60 cells. Error bars indicate standard deviations. b An average of
each transmission rate was determined by more than two crossings
Fig. 6 Flow cytometric analysis of surface molecules on splenocytes
from a chimeric mouse and F8 generation mouse. Cells were stained with
anti-HLA-DR, L243. A B6 mouse with no HAC was used as a negative
control for the chimeric mouse, and the B6 background for five filial
generations with HAC (no inserts) was used as a negative control for the
F8 generation mouse
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The HAC retention rate of tails was almost the same for the
same individual at 6 weeks and 7 months of age (Table 2,
Fig. 4a), and the HAC retention rate of the tail at 7 months was
the same as that of the brain, heart, kidney, and liver at
7 months. The HAC retaining an early developmental cell
proliferation stage in the TMC mouse may determine the
consequent HAC retention rate in the tail, brain, heart, kidney,
and liver. Thus, the HAC retention rate of the tail cells from
young mice is a good and easy index for estimating the
retention rate of these tissues. On the other hand, the retention
rate of the bone marrow and spleen was relatively lower at
7 months of age. Whether the retention rate of the bone
marrow and spleen will decrease with proliferating dependen-
cy requires further investigation.
Although the retention rates in the F1 mice harboring the
DRA-HAC and the HLA-HAC were variable in individual
mice, they were not significantly different on average (86.2
and 82.6 %, respectively). No significant decrease in stability
was observed in the previous analysis after inserting three
genes at different sites in the expression cassettes on the same
HAC vector when evaluating cultured cells (data not shown).
However, through the generations, significant differences
were observed in the transmission rates betweenmice carrying
the DRA-HAC and HLA-HAC. The DRA-HAC was gener-
ated by insertion of a 100-kb HLA-DRABAC into one of four
expression cassettes of the 25-4 HAC vector, whereas the
HLA-HAC was generated by insertion of an additional 50-
kb HLA-DRB1 BAC into another expression cassette. This
Fig. 7 Quantitative analysis of the expression of human transgenes in various tissues of TMC F8 mice. Each value was corrected by the level of mouse
GAPDH (see Supplemental Fig. S2)
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additional BAC insertion resulted in a significant decrease in
the transmission rate through mouse generations and influ-
enced the meiotic process in the germ line. The expression
patterns and levels of HLA-DRA and HLA-DRB1 from the
HAC vector were not significantly different and were restrict-
ed to immunocompetent mouse cells through the eight gener-
ations. Thus, the gene product from the additional HLA-
DRB1 gene is not likely to be more harmful in the germ line.
The additional BAC insertion at the separated expression
cassette site on this circular HAC vector may have some more
structural disadvantage through the meiotic process in the
germ line. Indeed, we did not observe such stability differ-
ences between the DRA-HAC and the HLA-HAC through the
HAC constructions in CHO cells and the HAC transfer until
generation of chimeric mice. The additional BAC insertion
may cause some structural change between the HAC centro-
mere and the heterochromatin, both of which are responsible
for the chromosome segregation and stability, and thought to
be more dynamically changing through cellular senescence
and between different types of cell lines (Maehara et al. 2010;
Ohzeki et al. 2012). One possible explanation is that the
differences of retention and transmission rates of the two
HACs may be strongly influenced by epigenetic changes
following mouse background conversion from BDF2 (ES) to
B6 through the germ line. Although it is interesting to ask why
an additional insertion decreases the stability of the circular
HAC, we have already taken measures against it. Using the
FLP-FRT system, HLA-DRA BAC and HLA-DRB1 BAC
will be introduced into one expression cassette of the 25-4
HAC vector. We also developed two new site-specific recom-
bination systems named VCre/VloxP and SCre/SloxP for
genome engineering; the recognition sequences are different
from the Cre recognition sequence (Suzuki and Nakayama
2011). These improvements enable us to introduce many
BACs into one of chosen expression cassettes of the 25-4
HAC vector.
Although some instability was observed based on the
manner of insertion, a de novo HAC vector carrying
multiple genomic BACs was transmitted through at least
eight generations, maintaining functional expression
over seven generations, which is the minimum required
for congenic breeding. We think that HAC vector tech-
nology opens up a new field that will offer advantages
for generating transgenic animals that harbor multiple,
large, single-copy DNA fragments and controlling the
tissue-specific expression of transgenes.
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